BIOLOGICAL E

South Africa to get 1.5 million COVID-19 vaccines from India

The vaccine, developed with the University of Oxford, is made from a virus which is a weakened version of a common cold virus (adenovirus),...

Bharat Biotech's Krishna Ella is a scientist who avoids any shortcuts

Ella never takes shortcuts and scientists at his foundation do more research work than probably any other institution in the country, say p...

CEPI to invest $5m in Biological E’s project

CEPI has also agreed to an initial contribution of up to $5 million to Hyderabad-based Biological E towards the cost of scaling up the proc...

India's Biological E. to start vaccine late-stage trials in April: Executive

The privately held company said in November it had started early-stage and mid-stage human trials of its vaccine candidate, being developed...

IFC invests $30m in Indian vaccine maker Biological E for future Covid vaccines, routine immunisation

IFC said its financing will help increase production of vaccines and, thus, competitiveness of the vaccine market geared toward the develop...

64 Heads of Missions arrive in Hyderabad to visit Bharat Biotech, Biological E Ltd

The 64 Heads of Missions in India arrive in Hyderabad on December 9. They are scheduled to visit Bharat Biotech, Biological E Ltd. The faci...

Capacity needed to manufacture Covid vaccines is unprecedented: DRL MD

Prasad in an exclusive interview to ET said that three challenges with the Covid vaccine distribution are the sheer capacity expansion that...

Biological E to start phase-III trials by January, license vaccine by summer

Disclosing this in Hyderabad on Monday, managing director Mahima Datla said the company is currently evaluating four different formulations...

Biological E gets DGCA nod to begin the next phase of trials for its COVID-19 vaccine

This vaccine candidate includes an antigen that was in-licensed from BCM Ventures, which is an integrated commercialisation team of Baylor ...

Biological E gets nod for human trials of Covid-19 vaccine

India’s drug regulator has allowed Hyderabad-based Biological E to start phase-1 and 2 human trials in India for a vaccine against Covid-19.

Drug regulator approves Hyderabad-based Biological E's phase I/II trials of Covid vaccine

Biological E has tied up with an undisclosed company and will be conducting the trials. The announcement about the tie up is likely to be m...

ICMR, Biological E Ltd develop potential treatment for COVID-19

The ICMR in collaboration with a Hyderabad-based biopharmaceutical company has developed "highly purified antisera" prepared by injecting i...

ICMR, Biological E develop purified equine antiserum

The therapy works like plasma therapy. However, the blood plasma is obtained from animals — from horses, in this case — that have recovered...

Biological E acquires Akorn India to ramp up vaccine & injectable medicine capacities

Akorn India, a subsidiary of the US-based Akorn Inc., has a manufacturing plant of 39,000 square metres over a 14-acre campus in Himachal P...

BE ties up with Janssen Pharmaceutica NV for coronavirus vaccine production

"We are very pleased indeed to collaborate with an organisation like Johnson & Johnson. Given the magnitude of COVID-19 pandemic, our abili...

Baylor College of Medicine and Biological E sign licensing pact to develop Covid-19 vaccine

BE in a statement on Thursday said it will leverage its experience to develop and commercialise the vaccine candidate, which currently is p...

Biological E signs pact with J&J for Covid-19 vaccine technology

Biological E will produce J&J's vaccine at its vaccine production facilities and sell them both in India and export across various global m...